Assessment of the Impact of Chemotherapeutic ‘Treatment Effect’ on Oncological Outcomes in Initially Node‐Positive Breast Cancer Patients Undergoing Sentinel Lymph Node Biopsy Only After Neoadjuvant Chemotherapy
Journal of Surgical Oncology · 2026-11 · 134 (6) · 888-894
DOI: 10.1002/jso.70369 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Surgical Oncology, online erschienen am 10.08.2026. Verfasst von Hussain A Abdulla und 14 weiteren Autor:innen. Beteiligte Einrichtung: Breast Surgery, St Vincent's University Hospital, Dublin, Ireland. Hauptthemen laut MEDLINE: Breast Neoplasms, Sentinel Lymph Node Biopsy, Neoadjuvant Therapy, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 33 Literaturangaben.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Sentinel lymph node biopsy (SLNB) is acceptable for patients who were initially node‐positive (cN+) and who achieve a complete radiological response after neoadjuvant chemotherapy (NACT). The impact of identifying chemotherapeutic ‘treatment effect’ (TE) in resected nodes on reducing false‐negative rates and oncological outcomes remains unclear. The aim of this study was to assess the impact of TE seen on SLNB and to determine oncological outcomes in this patient cohort. Methods cN+ breast cancer patients who received NACT and achieved nodal pathological complete response after SLNB only between 2014 and 2023 were assessed. Patients with negative SLNB (ypN0) were divided into two groups: (1) with TE and (2) without TE. Crude axillary recurrence rates were compared using the log‐rank test. Median disease‐free (DFS) and overall survival (OS) were compared using Kaplan−Meier curves.
Results
One hundred and fourteen patients were ypN0 after SLNB: 84 (73.7%) with TE and 30 (26.3%) without TE. Axillary recurrence trended towards a lower rate in those with TE (2.38% vs. 3.33%, p = 0.77). All patients with axillary recurrence had residual triple‐negative disease within the breast. There were no differences in median DFS (47.5 vs. 43.5 months, p = 0.91) and OS (53.5 vs. 44.5 months, p = 0.68) between the two groups, respectively.
Conclusion
Absence of TE in patients undergoing SLNB only does not appear to affect DFS and OS, but may increase the risk of axillary recurrence. Larger studies are needed to further determine the impact of TE on oncologic outcomes in these patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Breast Surgery, St Vincent's University Hospital, Dublin, Ireland.
- Medical Oncology, St Vincent's University Hospital, Dublin, Ireland.
- Histopathology, St Vincent's University Hospital, Dublin, Ireland.
ORCID-Profile: Hussain A Abdulla, Janice M Walshe, Cecily Quinn, Michael R Boland
Zitieren
APA
Abdulla, H. A., Matthew, M., Zaborowski, A. M., Rutherford, C. L., McCartan, D., Evoy, D., Rothwell, J., Higgins, M. J., Walshe, J. M., Crown, J. P., D'Arcy, C., Maguire, A., Quinn, C., Prichard, R. S., & Boland, M. R. (2026). Assessment of the Impact of Chemotherapeutic ‘Treatment Effect’ on Oncological Outcomes in Initially Node‐Positive Breast Cancer Patients Undergoing Sentinel Lymph Node Biopsy Only After Neoadjuvant Chemotherapy. Journal of Surgical Oncology, 134(6), 888-894. https://doi.org/10.1002/jso.70369
Vancouver
Abdulla HA, Matthew M, Zaborowski AM, Rutherford CL, McCartan D, Evoy D, et al. Assessment of the Impact of Chemotherapeutic ‘Treatment Effect’ on Oncological Outcomes in Initially Node‐Positive Breast Cancer Patients Undergoing Sentinel Lymph Node Biopsy Only After Neoadjuvant Chemotherapy. Journal of Surgical Oncology. 2026;134(6):888-894. doi:10.1002/jso.70369
BibTeX
@article{Abdulla2026,
author = {Abdulla, Hussain A and Matthew, Midhun and Zaborowski, Alexandra M and Rutherford, Claire L and McCartan, Damian and Evoy, Denis and Rothwell, Jane and Higgins, Michaela J and Walshe, Janice M and Crown, John P and D'Arcy, Clare and Maguire, Aoife and Quinn, Cecily and Prichard, Ruth S and Boland, Michael R},
title = {Assessment of the Impact of Chemotherapeutic ‘Treatment Effect’ on Oncological Outcomes in Initially Node‐Positive Breast Cancer Patients Undergoing Sentinel Lymph Node Biopsy Only After Neoadjuvant Chemotherapy},
journal = {Journal of Surgical Oncology},
year = {2026},
volume = {134},
number = {6},
pages = {888--894},
doi = {10.1002/jso.70369}
}
EUVIMED